Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Journal of Virology
|
January 31, 2020
Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38
Akaash K Mishra, Crystal L Moyer, Dafna M Abelson, et al.
Nature Structural & Molecular Biology
|
April 30, 2021
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins
Ha V Dang, Robert W Cross, Viktoriya Borisevich, et al.
The Journal of Infectious Diseases
|
September 9, 2024
A Longitudinal Analysis of Memory Immune Responses in Convalescent Crimean-Congo Hemorrhagic Fever Survivors in Uganda
Courtney A Cohen, Stephen Balinandi, Ana I Kuehne, et al.
Nature Communications
|
March 26, 2021
Combination therapy protects macaques against advanced Marburg virus disease
Robert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
NPJ Vaccines
|
March 5, 2020
Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin
Chad J Roy, Greta Van Slyke, Dylan Ehrbar, et al.
Cell Reports
|
September 15, 2015
Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail
Jeffrey R Kugelman, Johanny Kugelman-Tonos, Jason T Ladner, et al.
Science Translational Medicine
|
August 23, 2013
Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail
James Pettitt, Larry Zeitlin, Do H Kim, et al.
Pathogens (Basel, Switzerland)
|
June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
Erin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Frontiers in Immunology
|
August 2, 2021
Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
Pavlo Gilchuk, Adrian Guthals, Stefano R Bonissone, et al.
Cell Host & Microbe
|
April 23, 2020
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies
Philipp A Ilinykh, Kai Huang, Rodrigo I Santos, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Journal of Virology
|
January 31, 2020
Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38
Akaash K Mishra, Crystal L Moyer, Dafna M Abelson, et al.
Nature Structural & Molecular Biology
|
April 30, 2021
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins
Ha V Dang, Robert W Cross, Viktoriya Borisevich, et al.
The Journal of Infectious Diseases
|
September 9, 2024
A Longitudinal Analysis of Memory Immune Responses in Convalescent Crimean-Congo Hemorrhagic Fever Survivors in Uganda
Courtney A Cohen, Stephen Balinandi, Ana I Kuehne, et al.
Nature Communications
|
March 26, 2021
Combination therapy protects macaques against advanced Marburg virus disease
Robert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
NPJ Vaccines
|
March 5, 2020
Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin
Chad J Roy, Greta Van Slyke, Dylan Ehrbar, et al.
Cell Reports
|
September 15, 2015
Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail
Jeffrey R Kugelman, Johanny Kugelman-Tonos, Jason T Ladner, et al.
Science Translational Medicine
|
August 23, 2013
Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail
James Pettitt, Larry Zeitlin, Do H Kim, et al.
Pathogens (Basel, Switzerland)
|
June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
Erin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Frontiers in Immunology
|
August 2, 2021
Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
Pavlo Gilchuk, Adrian Guthals, Stefano R Bonissone, et al.
Cell Host & Microbe
|
April 23, 2020
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies
Philipp A Ilinykh, Kai Huang, Rodrigo I Santos, et al.
Page
of 10